Santiago Arroyo
Director/Board Member at H. LUNDBECK A/S
Net worth: 878 280 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alistair Milnes | M | 50 | 3 years | |
| Dominique Sirena | M | - |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
| Amir Faridmoayer | M | - |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
| Ganesh Venkataraman Kaundinya | M | 57 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 4 years |
| Michael Skynner | M | 55 | 11 years | |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 9 years | |
| Kevin Lee | M | 55 | 12 years | |
| Lars Søren Rasmussen | M | 65 | 11 years | |
| Travis Thompson | M | - | 6 years | |
| Helen Hobbs | M | 71 | 13 years | |
| Stephen Sands | M | 67 | - | |
| Jeremy Levin | M | 70 | 7 years | |
| Jeffrey Berkowitz | M | 58 | 6 years | |
| Gregory Winter | M | 73 | 15 years | |
| Lene Skole-Sørensen | F | 65 | 9 years | |
| Joseph Echevarria | M | 66 | 9 years | |
| Jim Smith | M | 64 | 10 years | |
| Lars Erik Holmqvist | M | 64 | 9 years | |
| Janice Bourque | F | 67 | 5 years | |
| Lars Bang | M | 61 | 36 years | |
| Shantanu Narayen | M | 60 | 11 years | |
| Richard Kender | M | 68 | 5 years | |
| Dorothea Wenzel | M | 55 | 3 years | |
| Charl van Zyl | M | 57 | 1 years | |
| Dorte Clausen | F | 40 | 2 years | |
| Hossein Armandi | M | 62 | 2 years | |
| Camilla Andersson | F | 52 | 2 years | |
| Thomas Mikkel Mortensen | M | - | - | |
| Denis Patrick | M | - | 14 years | |
| Lasse Skibsbye | M | 41 | 2 years | |
| David Borah | M | - | 3 years | |
| James Sutcliffe | M | 68 | 1 years | |
| Thomas Edward Gibbs | M | 53 | 1 years | |
| Steve Danehy | M | - | 12 years | |
| Tarek Samad | M | - | 3 years | |
| Jennifer Perry | F | - | - | |
| Sonya Weigle | F | - | 3 years | |
| Zafar Qadir | M | - | 4 years | |
| Johan Luthman | M | 65 | 5 years | |
| Pierre Legault | M | 63 | 5 years | |
| Nicholas Keen | M | 56 | 7 years | |
| Keld Flintholm Jørgensen | M | 53 | 5 years | |
| Philippe Dro | M | 61 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 2 years |
| Mira Chaurushiya | M | - |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
| Jörg Hornstein | M | 47 | 2 years | |
| Palle Holm Olesen | M | - | - | |
| Ivan Cheung | M | 47 | 19 years | |
| Juliane Lenzner | F | - | - | |
| Jakob Riis | M | 58 | 1 years | |
| Alethia Young | F | 45 | 1 years | |
| Kush Parmar | M | 42 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 2 years |
| Monique Schiersing | M | - |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
| Graziano Seghezzi | M | 55 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
| Nigel Crockett | M | 59 | 5 years | |
| Georges Gemayel | M | 64 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Kindler | M | 68 | 8 years | |
| William Steere | M | 87 | 28 years | |
| Deborah Dunsire | M | 61 | 5 years | |
| Amy Schulman | F | 63 | 6 years | |
| George A. Lorch | M | 82 | 15 years | |
| Lee Kalowski | M | 43 | 6 years | |
| Michael Dougherty | M | 66 | 5 years | |
| Robert Landry | M | 60 | 4 years | |
| Yi Ning Zhao | M | 53 | 8 years | |
| Elise Hauge | F | 57 | 4 years | |
| Everett Cunningham | M | 57 | 9 years | |
| John Mascotte | M | 84 | 4 years | |
| Marc Tessier-Lavigne | M | 64 | 4 years | |
| Jacob Tolstrup | M | 52 | 25 years | |
| Anders Götzsche | M | 56 | 15 years | |
| Shinji Hatta | M | - | 4 years | |
| Veronica Jordan | M | 73 | 5 years | |
| Michael Brown | M | 82 | 16 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Robert N. Burt | M | 86 | 11 years | |
| William Herbert Gray | M | 82 | 13 years | |
| M. Anthony Burns | M | 81 | 25 years | |
| Nicole Vitullo | F | 66 | 17 years | |
| Alan Mendelsohn | M | 62 | 2 years | |
| Baiyong Li | M | 56 | 12 years | |
| David Peritt | M | 60 | 1 years | |
| Margaret Marshall | M | 67 | 8 years | |
| Soma Gupta | F | - | 6 years | |
| Barry Ticho | M | 64 | 3 years | |
| Venkat Reddy | M | - | 2 years | |
| Premal Patel | M | 54 | 2 years | |
| Brian Krex | M | 57 | 9 years | |
| Carl Morris | M | 54 | 5 years | |
| Valerie Start | M | 64 | 3 years | |
| Margaret McLoughlin | M | 61 | 5 years | |
| William C. Kennally | M | 67 | 5 years | |
| Ronald Shazer | M | 56 | 1 years | |
| Dieter Weinand | M | 63 | 3 years | |
| John Paolini | M | 59 | 1 years | |
| Charles Baum | M | 65 | 9 years | |
| David Roblin | M | 57 | 3 years | |
| Adele Gulfo | F | 61 | 5 years | |
| Martine George | M | 76 | 5 years | |
| Vatnak Vat-Ho | M | - | 4 years | |
| Leanna Bautista | F | 41 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 48 | 48.00% |
| Denmark | 25 | 25.00% |
| United Kingdom | 19 | 19.00% |
| Switzerland | 9 | 9.00% |
| Japan | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Santiago Arroyo
- Personal Network